Erenumab

1 Drug classified under this active ingredient

CGRP, Human Monoclonal Antibody. Erenumab 70 mg.
PRE-FILL. SYR (sol. for S.C. inj.): 1
PRE- FIL. PEN (sol. for S.C. inj.): 1
Tmt. is intend. for pts. with at least 4 migraine days per month when initiat. tmt. with erenumab.
The recomm. dose is 70 mg erenumab every 4 wks. Some pts. may benefit from a dose of 140 mg every 4 wks.
Each 140 mg dose is given as two S.C. inj. of 70 mg. See lit.
Tmt. should be initiat. by physicians experienced in the diagnosis and tmt. of migraine.
C/I: Hypersens.